日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

[Kuwanon G inhibits growth, migration and invasion of gastric cancer cells by regulating the PI3K/AKT/mTOR pathway].

[Kuwanon G 通过调节 PI3K/AKT/mTOR 通路抑制胃癌细胞的生长、迁移和侵袭]

Geng Z, Yang J, Niu M, Liu X, Shi J, Liu Y, Yao X, Zhang Y, Zhang X, Hu J

[Acetylcorynoline relieves 2, 4, 6-trinitrobenesulfonic acid-induced Crohn's disease-like colitis in mice by regulating intestinal epithelial cell apoptosis]

[乙酰基康诺林通过调节肠上皮细胞凋亡缓解2,4,6-三硝基苯磺酸诱导的小鼠克罗恩病样结肠炎]

Li, Q; Huang, J; Sun, Y; Xu, Y; Wang, L; Zhang, X; Wang, Y; Geng, Z; Song, X; Zuo, L; Li, J; Hu, J

[High expression of CAMSAP2 promotes invasion and metastasis of gastric cancer cells by upregulating TGF-β signaling].

[CAMSAP2的高表达通过上调TGF-β信号促进胃癌细胞的侵袭和转移]

Zuo L, Wang L, Yang Z, Li J, Wang W, Li J, Wang Y, Song X, Zhnag X, Geng Z

Fluid shear stress-induced down-regulation of miR-146a-5p inhibits osteoblast apoptosis via targeting SMAD4

流体剪切应力诱导的 miR-146a-5p 下调通过靶向 SMAD4 抑制成骨细胞凋亡

X Liu, K Zhang, L Wang, B Geng, Z Liu, Q Yi, Y Xia

Efficacy and safety of risankizumab vs. secukinumab in patients with moderate-to-severe plaque psoriasis (IMMerge): results from a phase III, randomized, open-label, efficacy-assessor-blinded clinical trial

利沙珠单抗与司库奇尤单抗治疗中重度斑块状银屑病患者的疗效和安全性比较(IMMerge):一项 III 期随机、开放标签、疗效评估者盲法临床试验的结果

Warren, R B; Blauvelt, A; Poulin, Y; Beeck, S; Kelly, M; Wu, T; Geng, Z; Paul, C

Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trials

每周一次的阿达木单抗治疗在 36 周内降低了化脓性汗腺炎的疾病复发率:来自 3 期 PIONEER 试验的综合结果

van der Zee, H H; Longcore, M; Geng, Z; Garg, A

[Clinical outcomes of vocal fold immobility after tracheal intubation]

[气管插管后声带麻痹的临床结果]

Geng, Z Y; Gao, W H; Wang, D X

Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials

阿达木单抗治疗中重度化脓性汗腺炎的中期给药策略:来自 III 期随机安慰剂对照 PIONEER 试验的综合结果

Jemec, G B E; Okun, M M; Forman, S B; Gulliver, W P F; Prens, E P; Mrowietz, U; Armstrong, A W; Geng, Z; Gu, Y; Williams, D A; Teixeira, H D; Kimball, A B

Adalimumab for nail psoriasis: efficacy and safety over 52 weeks from a phase-3, randomized, placebo-controlled trial

阿达木单抗治疗指甲银屑病:一项3期随机、安慰剂对照试验的52周疗效和安全性

Elewski, B E; Baker, C S; Crowley, J J; Poulin, Y; Okun, M M; Calimlim, B; Geng, Z; Reyes Servin, O; Rich, P A

Modulators for Terahertz Communication: The Current State of the Art

太赫兹通信调制器:当前技术水平

Ma, Z T; Geng, Z X; Fan, Z Y; Liu, J; Chen, H D